La vendita allo scoperto per SRAX dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di SRAX. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

SRAX (OTC:SRAX) Azioni, Report sulle vendite allo scoperto

SRAX

SRAX Inc is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track investor's behavior and trends and use those insights to engage current and potential investors across marketing channels.

Social Reality

SRAX Inc

RBC Capital analyst Arun Viswanathan maintains Federated Hermes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHI#NYSE">FHI</a>) with a Sector Perform and raises the price target from $43 to $45.

News

Price Target

Analyst Ratings

RBC Capital Maintains Sector Perform on Federated Hermes, Raises Price Target to $45

Benzinga readers think Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk should focus on his companies instead of launching a <a href="https://www.benzinga.com/news/politics/25/07/46210411/musk-third-party-odds-hit-47-can-the-tesla-chief-do-what-no-one-has-since-1853">new political party.</a>
What Happened: Musk is considering launching <a href="https://www.benzinga.com/news/politics/25/07/46265725/elon-musk-announces-formation-of-america-party-emerges-in-wake-of-donald-trumps-historic-spending-bill">the America Party, </a>which could provide a third-party option in races for House of Representatives and Senate seats in the 2026 midterms and could even provide a challenge in the 2028 presidential election to the two main parties.
Musk has become increasingly involved in politics in recent years, making large donations to support Donald Trump&#8216;s 2024 presidential campaign and securing a role in the White House&#8217;s Department of Government Efficiency earlier this year.
Benzinga recently asked readers if this should be Musk's focus going forward.
"Elon Musk is wading deeper into politics. Should he stay focused on Tesla and SpaceX — or keep speaking out?" Benzinga asked
The results were:
<ul class="wp-block-list">
<li>Stay focused on his companies: 74%</li>
<li>Do both – he can multitask: 21%</li>
<li>Keep speaking out: 5%</li>
</ul>
A large majority of readers polled said Musk should stay focused on his companies. Musk is the CEO of Tesla and SpaceX and is also involved with several other companies, including Neuralink and X. With the recent announcement that X CEO Linda Yaccarino <a href="https://www.benzinga.com/news/social-media/25/07/46329375/x-ceo-yaccarino-splits-with-elon-musk-after-two-years-says-best-is-yet-to-come-for-social-platform" target="_blank" rel="noopener">is stepping down,</a> Musk&#8217;s time commitment to the social media platform may increase.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul class="wp-block-list">
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Why It's Important: Musk is the wealthiest person in the world and has a considerable influence as the most followed person on X. His push into politics could change the future of the current two-party system in America, but also could take time away from other key focuses for the billionaire.
Musk has been instrumental in transforming the electric vehicle, clean energy and space sectors for the better, and without his strong commitment to these ideals and the companies involved, technology could face a setback.
Wedbush analyst Dan Ives recently said Tesla's Board needs to "act now" and put rules in place for Musk to manage his time in politics <a href="https://www.benzinga.com/news/politics/25/07/46300946/musk-vs-trump-soap-opera-must-end-tesla-analyst-shares-3-key-steps">and at Tesla.</a>
&#8220;Tesla is heading into one of the most important stages of its growth cycle with the autonomous and robotics future now on the doorstep and cannot have Musk spending more and more time creating a political party which will require countless time, energy, and political capital,&#8221; Ives said, adding that this &#8220;soap opera must end.&#8221;
Ives said Tesla investors want Musk to remain as CEO for at least five more years and to focus on the company's autonomous and robotics future. The analyst called Nvidia and Tesla the best physical AI companies in the world, with autonomous vehicles worth around a $1 trillion potential in Tesla's valuation.
TSLA Price Action: Tesla stock closed at $295.88 on Wednesday versus a 52-week trading range of $182.00 to $488.54. Tesla stock is down 22% year-to-date in 2025 and could fall further if Musk spends more time away from the EV giant.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46285761/can-elon-musk-run-for-president-or-even-be-speaker-of-the-house">Can Elon Musk Run For President — Or Even Be Speaker Of The House?</a></li>
</ul>
The study was conducted by Benzinga from July 7, 2025, through July 8, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 55 adults.
Photo: Shutterstock

Politics

TSLA

Musk's Politics Or Tesla's Future? 74% Say The Choice Is Clear

Goldman Sachs analyst Corinne Johnson initiates coverage on Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) with a Buy rating and announces Price Target of $18.

Initiation

SNDX

Goldman Sachs Initiates Coverage On Syndax Pharmaceuticals with Buy Rating, Announces Price Target of $18

RBC Capital analyst Arun Viswanathan maintains Cannae Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNNE#NYSE">CNNE</a>) with a Outperform and raises the price target from $22 to $26.

CNNE

RBC Capital Maintains Outperform on Cannae Holdings, Raises Price Target to $26

RBC Capital analyst Arun Viswanathan maintains Artisan Partners Asset (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APAM#NYSE">APAM</a>) with a Outperform and raises the price target from $44 to $50.

APAM

RBC Capital Maintains Outperform on Artisan Partners Asset, Raises Price Target to $50

Goldman Sachs analyst Corinne Johnson initiates coverage on Neurocrine Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) with a Buy rating and announces Price Target of $182.

NBIX

Goldman Sachs Initiates Coverage On Neurocrine Biosciences with Buy Rating, Announces Price Target of $182

AI-Driven Energy Pioneer Delivers Sixth Consecutive Record Month
Company on Clear Path to $100 Million Revenue Run-Rate with Canadian Acquisition
MIAMI, July 10, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXXT#NASDAQ">NXXT</a>), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered through its Next Utility Operating System&#xAE;, smart microgrids, wireless EV charging, and mobile fuel delivery, today announced preliminary unaudited financial results for June 2025.
June 2025 Highlights:
<ul>
<li>Revenue: $6.98 million, up 231% year-over-year and 6% month-over-month</li>
<li>Gallons delivered: Over 2.04 million gallons, up 270% year-over-year and 4% month-over-month</li>
<li>Year-to-date revenue through June reached approximately $35.87 million, representing a 33% increase over full-year 2024 revenue of approximately $27 million</li>
</ul>

NXXT

NextNRG Preliminary June 2025 Revenue Surges 231% Y/Y To $6.98M

Goldman Sachs analyst James Schneider initiates coverage on Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) with a Neutral rating and announces Price Target of $90.

QRVO

Goldman Sachs Initiates Coverage On Qorvo with Neutral Rating, Announces Price Target of $90

RBC Capital analyst Arun Viswanathan maintains Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) with a Outperform and raises the price target from $565 to $595.

RBC Capital Maintains Outperform on Ameriprise Finl, Raises Price Target to $595

<ul>
<li>Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatric &amp; Robotic Surgery Centre in Indore, India.</li>
<li>Two advanced One-Anastomosis Gastric Bypass (OAGB) procedures were performed via telesurgery, with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system.</li>
</ul>
FORT LAUDERDALE, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LXk68Zn9u8Lo5Lt1N2xDPtRZQaSJGsUeL6id-8x5QojmwvojHxhAKcJzUs9TlYGC378cOrWefJD61kcl8FJjKomGkvbTKXJm4o6u2pcS44ex-otaCjQ0fJG_D33XBJYC">SS Innovations International, Inc.</a> (the "Company" or "SS Innovations") (NASDAQ:<a href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the world's first robotic telesurgery for weight loss utilizing the Company's advanced SSi Mantra 3 surgical robotic system.
This landmark bariatric telesurgery bridged a distance of 560 miles between SS Innovations' headquarters in Gurugram, India and the Mohak Bariatric &amp; Robotic Surgery Centre in Indore, India. Despite the vast distance, the surgery was performed with zero perceptible lag, flawless precision, and seamless robotic control, setting a new global benchmark for remote surgery capabilities.
The procedures involved two One-Anastomosis Gastric Bypass (OAGB) surgeries, an advanced form of bariatric surgery that reduces stomach size and reroutes the digestive tract to support long-term weight loss and improve metabolic health. The robotic procedures were successfully performed by Dr. Mohit Bhandari, a renowned bariatric surgeon, President of IRCAD India, and Founder &amp; Director of Mohak Bariatric &amp; Robotic Surgery Centre, Indore. Operating from Gurugram, Dr. Bhandari remotely led his Indore-based surgical team, which provided on-site assistance, ensuring expert execution and clinical excellence throughout.

Global

SSII

SS Innovations Completes World's First Robotic Telesurgery For Weight Loss Across 560 Miles In India

Goldman Sachs analyst James Schneider initiates coverage on ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Neutral rating and announces Price Target of $60.

Goldman Sachs Initiates Coverage On ON Semiconductor with Neutral Rating, Announces Price Target of $60

RBC Capital analyst Arun Viswanathan maintains Acadian Asset Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAMI#NYSE">AAMI</a>) with a Sector Perform and raises the price target from $29 to $34.

AAMI

RBC Capital Maintains Sector Perform on Acadian Asset Management, Raises Price Target to $34

Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) shares rose in premarket trading Thursday after the Atlanta-based carrier posted stronger-than-expected <a href="https://www.benzinga.com/pressreleases/25/07/n46338489/delta-air-lines-announces-june-quarter-2025-financial-results" target="_blank" rel="noreferrer noopener">second-quarter results</a> and reinstated its full-year 2025 guidance.
Operating revenue for the quarter was $16.65 billion, flat from a year ago but above the <a href="https://www.benzinga.com/earnings">consensus estimate</a> of $16.18 billion. Adjusted operating revenue rose 1% year over year to $15.51 billion.
Delta credited its June-quarter revenue, a 1% year-over-year increase, to continued strength in high-margin segments. Premium cabin sales rose 5%, loyalty revenue climbed 8%, American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) remuneration increased 10% to $2 billion, while adjusted unit revenue declined 3% amid 4% capacity growth.
Also Read: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46204250/airline-stocks-face-flat-q2-but-1-thing-could-lift-them" target="_blank" rel="noreferrer noopener">Airline Stocks Face Flat Q2—But 1 Thing Could Lift Them</a>
Adjusted earnings per share were $2.10, down 11% from the year-ago period but topping expectations of $2.05. The airline&#8217;s adjusted average fuel price fell to $2.26 per gallon, compared with $2.64 last year.
Passenger revenue surged 26% to $13.88 billion, while cargo revenue rose 7% to $212 million. Other revenue declined 2% to $2.57 billion.
Delta reported adjusted operating income of $2.05 billion, down from $2.27 billion a year earlier. Adjusted operating margin narrowed to 13.2% from 14.7%.
Adjusted operating cash flow totaled $1.84 billion, a 25% decline year over year, while free cash flow stood at $733 million.
As of the end of the June quarter, Delta reported adjusted net debt of $16.32 billion, down $1.7 billion from the end of 2024. Total liquidity was $6.4 billion, including $3.1 billion in undrawn revolver capacity.
The passenger load factor declined to 86% from 87% a year ago. Air traffic liability stood at $8.9 billion.
During the quarter, Delta announced new or expanded partnerships with WestJet, LATAM, IndiGo, and Virgin Atlantic, strengthening its global network and international connectivity.
&#8220;As we look to the second half of our centennial year, we remain focused on executing our strategic priorities and managing the levers within our control to deliver strong earnings and cash flow.&nbsp; Reflecting our confidence in the business, we are restoring financial&nbsp;guidance&nbsp;with an expectation for earnings per share of&nbsp;$5.25&nbsp;to&nbsp;$6.25&nbsp;and free cash flow of&nbsp;$3&nbsp;to&nbsp;$4 billion, consistent with our long-term free cash flow targets,&#8221; commented Ed Bastian, Delta&#8217;s chief executive officer.
Delta President Glen Hauenstein noted, &#8220;Through the quarter, demand trends stabilized at levels that are flat to last year and we continued to see resilience in our diverse, high-margin revenue streams.&#8221;
In June, DAL <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/n46013647/delta-air-lines-declares-quarterly-dividend" rel="noreferrer noopener">announced</a> a 25% increase to its quarterly dividend, raising it to $0.1875 per share. The payout is set for Aug. 21 to shareholders of record as of July 31.
<h2 class="wp-block-heading">2025 Outlook</h2>
Delta reinstated its full-year 2025 guidance, projecting earnings per share of $5.25 to $6.25, compared to the consensus estimate of $5.42. The airline also expects free cash flow of $3 billion to $4 billion.
&#8220;For the September quarter, we expect total revenue to be flat to up 4% compared to the prior year, with unit revenue trends expected to improve through the second half of the year as we continue to adjust capacity and the industry further rationalizes supply,&#8221; commented Glen Hauenstein, Delta&#8217;s president.
<h2 class="wp-block-heading">Third-Quarter 2025 Outlook</h2>
Delta forecasts total revenue to rise 0% to 4% year over year, with an operating margin between 9% and 11%. Adjusted earnings per share are projected to range from $1.25 to $1.75, versus a consensus estimate of $1.34.
Delta expects the September quarter to deliver its strongest non-fuel unit cost performance of the year, with costs projected to remain flat or decline slightly compared to 2024.
Price Action: DAL shares were trading higher by 12.03% to $56.76 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46336395/senate-confirms-trump-pick-bryan-bedford-as-faa-chief-even-as-chuck-schumer-warns-he-will-prioritize-profits-over-passenger-safety" target="_blank" rel="noreferrer noopener">Senate Confirms Trump Pick Bryan Bedford As FAA Chief Even As Chuck Schumer Warns He Will Prioritize &#8216;Profits Over Passenger Safety&#8217;</a></li>
</ul>
Photo by Angel DiBilio via Shutterstock

Earnings

Guidance

Movers

Delta Air Lines CEO Confident In Stronger 2025 As Demand Holds Steady

Goldman Sachs analyst James Schneider initiates coverage on Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) with a Sell rating and announces Price Target of $70.

SWKS

Goldman Sachs Initiates Coverage On Skyworks Solutions with Sell Rating, Announces Price Target of $70

Goldman Sachs analyst James Schneider initiates coverage on Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Buy rating and announces Price Target of $285.

Goldman Sachs Initiates Coverage On Analog Devices with Buy Rating, Announces Price Target of $285

Goldman Sachs analyst James Schneider initiates coverage on Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy rating and announces Price Target of $88.

MCHP

Goldman Sachs Initiates Coverage On Microchip Technology with Buy Rating, Announces Price Target of $88

RBC Capital analyst Arun Viswanathan maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Sector Perform and raises the price target from $40 to $47.

RBC Capital Maintains Sector Perform on FMC, Raises Price Target to $47

RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Outperform and raises the price target from $74 to $85.

CTVA

RBC Capital Maintains Outperform on Corteva, Raises Price Target to $85

Goldman Sachs analyst James Schneider initiates coverage on Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Buy rating and announces Price Target of $225.

Goldman Sachs Initiates Coverage On Texas Instruments with Buy Rating, Announces Price Target of $225

<a href="https://d1io3yog0oux5.cloudfront.net/_cc809716af22826d6b497dbdf8d85863/omegahealthcare/db/2905/27976/pdf/Omega+Healthcare+-+New+Investor+Presentation+-+July+10+2025+v1.pdf" title="https://d1io3yog0oux5.cloudfront.net/_cc809716af22826d6b497dbdf8d85863/omegahealthcare/db/2905/27976/pdf/Omega+Healthcare+-+New+Investor+Presentation+-+July+10+2025+v1.pdf">https://d1io3yog0oux5.cloudfront.net/_cc809716af22826d6b497dbdf8d85863/omegahealthcare/db/2905/27976/pdf/Omega+Healthcare+-+New+Investor+Presentation+-+July+10+2025+v1.pdf</a>

Comments

SRAX

Vendite allo scoperto

SRAX (OTC:SRAX) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO